Heart Failure Clinical Trials
151 studies are recruiting for heart failure in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 5
-
Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
The goal of this clinical trial is to learn if increasing the dose of diuretics to achieve a higher urine sodium target produces better clinical results when treating patients hospitalized with acute heart failure when compared to lower urine sodium target and standard of care. The main questions i…
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- Lakeland Regional Hospital, Lakeland, Florida
- Run by
- Lakeland Regional Health Systems, Inc.
-
CardioMEMS HF System Coverage With Evidence Development Study
The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Abbott, Pleasanton, California
- Run by
- Abbott Medical Devices
-
Forge AHEAD: Feasibility of Yoga to Improve Cognitive Function
The investigators will conduct a two-phase pilot study to test the feasibility and acceptability of a 12-week Chair Yoga intervention for 20 heart-failure patients. Using a patient-centered approach, investigators will involve stakeholders in designing the protocol, gather patient feedback, and ref…
- Stage
- Not phased
- Ages
- 55 and older
- Site
- Auburn University, Auburn, Alabama
- Run by
- Auburn University
-
Precision Rehabilitation for Veterans With (HFpEF)
This study is being completed because there is conflicting information regarding the value of monitored exercise in patients with heart failure with preserved ejection fraction (HFpEF). The purpose of this study is to collect baseline information necessary for researchers to pursue a larger study e…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Columbia VA Health Care System, Columbia, South Carolina
- Run by
- Columbia VA Health Care System
-
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 diabetes (T1D) remains unknown because …
- Stage
- Phase 3
- Ages
- 18 to 75
- Site
- Stanford University Medical Center, Stanford, California
- Locations
- 19 in total
- Run by
- Alessandro Doria
-
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- UC San Diego Health, La Jolla, California
- Locations
- 14 in total
- Run by
- XVIVO Perfusion
-
Home Hospital for Suddenly Ill Adults
The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and impro…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Brigham and Women's Hospital, Boston, Massachusetts
- Locations
- 2 in total
- Run by
- Brigham and Women's Hospital
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
Pilot Prospective Randomized Unblinded Pragmatic Trial of Pulmonary Artery Hemodynamic Monitoring Following Hospitalization for Cardiogenic Shock
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Inova Fairfax Medical Campus, Falls Church, Virginia
- Run by
- Inova Health Care Services
-
Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV
Heart failure (HF) is a growing health and economic burden around the globe, and it remains a leading cause of morbidity and mortality among the general population. HIV is recognized as an independent risk factor for HF, due to direct and indirect effects. Furthermore, people living with HIV (PLWH)…
- Stage
- Not phased
- Ages
- 40 and older
- Site
- University of Washington, Seattle, Washington
- Locations
- 2 in total
- Run by
- University of Washington
-
Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome
The overall objective of this study is to determine whether the addition of SGLT2 inhibitors to usual care in hospitalized patients with heart failure associated acute kidney injury is safe and efficacious. Investigators will assess if SGLT2 inhibition improves a composite cardio-renal outcome (mor…
- Stage
- Phase 2
- Ages
- 18 to 85
- Site
- Yale New Haven Hospital-St. Raphael Campus, New Haven, Connecticut
- Locations
- 2 in total
- Run by
- Yale University
-
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
This is a single-center, non-randomized study.The study staff will use the InSpectraTM tissue oxygen saturation (StO2) monitor manufactured by Hutchinson Technology to measure baseline StO2 levels after applying the noninvasive probe to the thenar eminence. After a stable reading is obtained, a blo…
- Stage
- Not phased
- Ages
- Up to 25
- Site
- University of Florida, Gainesville, Florida
- Run by
- University of Florida
-
Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System
The Yale HF Registry is a live EHR based registry that allows for retrospective and real-time monitoring of Heart Failure case across the Yale New Haven Health System.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Yale New Haven Health System, New Haven, Connecticut
- Run by
- Yale University
-
Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure
VAPP-HF is a prospective, multi-center, observational study assessing whether daily voice recordings analyzed by a machine learning algorithm can detect changes in pulmonary arterial (PA) pressure in heart failure patients with implanted PA pressure sensors (e.g., CardioMEMS, Cordella). Patients ac…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of California, San Francisco (UCSF), San Francisco, California
- Locations
- 3 in total
- Run by
- Noah Labs
-
Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
The purpose of this research study is to determine the effectiveness of low dose colchicine (LoDoCo) on measures of exercise capacity, physical function, frailty, and quality of life, among patients with heart failure with chronic stable preserved ejection fraction (HFpEF) and systemic inflammation…
- Stage
- Phase 2
- Ages
- 50 and older
- Site
- UT Southwestern Medical Center, Dallas, Texas
- Run by
- University of Texas Southwestern Medical Center
-
AI-Guided Left Bundle Branch Area Pacing
The purpose of this study is to compare the effectiveness of AI-guided LBBAP versus conventional LBBAP (not AI-guided) in improving CRT response rates and clinical outcomes.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic in Rochester, Rochester, Minnesota
- Run by
- Mayo Clinic
-
Identifying Markers of Exercise Training in Heart Failure
The heart failure syndrome that occurs when the heart is too sick to properly do its job. One of the main symptoms is difficulty with exercise. One way to improve symptoms is to start patients in a 12 week exercise program called cardiac rehabilitation. Cardiac rehabilitation been shown to improve …
- Stage
- Not phased
- Ages
- 18 to 89
- Site
- Stanford Health Care, Stanford, California
- Run by
- Stanford University
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
The primary objective of CHAPERONE solution is to evaluate the efficacy of engaging, assessing, and enabling long term treatment strategy with Health Artificial Intelligence (AI) Chatbot, Copilot, Large Language Model (LLM) and vital sign monitoring device in reducing CKM disease burden using an al…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Gilbert Cardiology, Gilbert, Arizona
- Locations
- 5 in total
- Run by
- Aventyn, Inc.
-
Heart Failure Precision Medicine Study
The study aims to test the hypothesis that multi-omics studies can identify Heart Failure profiles at risk of adverse outcomes and evaluate a telemonitoring intervention in the optimization of guideline-directed medical therapy.
- Stage
- Not phased
- Ages
- 21 and older
- Site
- UC Davis Medical Center, Sacramento, California
- Run by
- University of California, Davis
-
His-Bundle Corrective Pacing in Heart Failure
The investigators aim to prospectively evaluate the efficacy and mechanism of benefit of His-bundle pacing enhanced cardiac resynchronization therapy (His-CRT) vs. cardiac resynchronization therapy (BIV-CRT) in patients with heart failure and right bundle branch block (RBBB).
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Arizona, Phoenix, Arizona
- Locations
- 14 in total
- Run by
- University of Rochester
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
The goal of this factorial randomized trial is to examine the independent and synergistic efficacies of two mobile health technology interventions in people with chronic heart failure. The first intervention involves the use of multiple consumer mHealth apps and sensor devices (MyApps) for heart fa…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Rush University Medical Center, Chicago, Illinois
- Locations
- 2 in total
- Run by
- University of Illinois at Chicago
-
Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
This phase II, multi-center, open-label study will evaluate the safety and efficacy of utilizing HCV-positive donors for heart transplant in HCV-negative recipients treated with sofosbuvir 400 mg / velpatasvir 100 mg (Epclusa®).
- Stage
- Phase 2
- Ages
- 18 to 90
- Site
- Cedars-Sinai Medical Center, Los Angeles, California
- Locations
- 3 in total
- Run by
- Baylor Research Institute
-
Cardiopulmonary Stress Testing (CPET) AlloSure Study
1. Cell-free DNA does not vary significantly as a function of the activity of immunologically quiescent cardiac transplant recipients, despite the metabolic demands of the transplanted organ. (The implication of the null result would be that no restrictions to patient activity, nor modification of …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Baylor Scott & White health research institute, Dallas, Texas
- Run by
- Baylor Research Institute
-
Sensor-controlled Digital Game for Heart Failure Self-management: A Clinical Trial
This study evaluates a sensor-controlled digital game (SCDG) to motivate self-management behaviors of weight monitoring and physical activity in adults with heart failure (HF). Half of the participants will receive the SCDG app and weight monitoring and physical activity sensors and the other half …
- Stage
- Not phased
- Ages
- 45 and older
- Site
- The University of Texas Austin, Austin, Texas
- Run by
- University of Texas at Austin
-
Effect of Music on Cardiopulmonary Exercise Capacity in Heart Failure Patients
The study aims to assess the effect of music on the heart resulting in a change in their exercise capacity among systolic heart failure patients undergoing Cardiopulmonary Exercise testing.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Kentucky, Lexington, Kentucky
- Run by
- Maya Ignaszewski
-
Diffusion MRI in Heart Failure
The development of symptomatic heart failure is frequently preceded by a pre-clinical period of structural remodeling in the heart. The remodeling process driving this transition, however, remains poorly understood. The investigators hypothesize that imaging the diffusion of water in the heart with…
- Stage
- EARLY_Phase 1
- Ages
- 18 to 85
- Site
- Massachusetts General Hospital, Charlestown, Massachusetts
- Run by
- Massachusetts General Hospital
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.